131 related articles for article (PubMed ID: 9816125)
1. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain.
Obiri NI; Husain SR; Debinski W; Puri RK
Clin Cancer Res; 1996 Oct; 2(10):1743-9. PubMed ID: 9816125
[TBL] [Abstract][Full Text] [Related]
2. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
Obiri NI; Puri RK
Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
[TBL] [Abstract][Full Text] [Related]
3. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
Kuznetsov VA; Puri RK
Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.
Morisaki T; Yuzuki DH; Lin RT; Foshag LJ; Morton DL; Hoon DS
Cancer Res; 1992 Nov; 52(21):6059-65. PubMed ID: 1394231
[TBL] [Abstract][Full Text] [Related]
6. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Menetrier-Caux C; Thomachot MC; Alberti L; Montmain G; Blay JY
Cancer Res; 2001 Apr; 61(7):3096-104. PubMed ID: 11306493
[TBL] [Abstract][Full Text] [Related]
7. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
Kawakami K; Leland P; Puri RK
Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
[TBL] [Abstract][Full Text] [Related]
8. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
[TBL] [Abstract][Full Text] [Related]
9. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
10. Immunostaining of interleukin-4 receptor on human renal cell carcinoma.
Varricchio F; Obiri NI; Haas GP; Puri RK
Lymphokine Cytokine Res; 1993 Dec; 12(6):465-9. PubMed ID: 8123763
[TBL] [Abstract][Full Text] [Related]
11. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells.
Murata T; Obiri NI; Debinski W; Puri RK
Biochem Biophys Res Commun; 1997 Sep; 238(1):90-4. PubMed ID: 9299458
[TBL] [Abstract][Full Text] [Related]
12. The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor.
He YW; Malek TR
J Immunol; 1995 Jul; 155(1):9-12. PubMed ID: 7602126
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.
Ménétrier-Caux C; Bain C; Favrot MC; Duc A; Blay JY
Br J Cancer; 1999 Jan; 79(1):119-30. PubMed ID: 10408703
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.
Serve H; Oelmann E; Herweg A; Oberberg D; Serve S; Reufi B; Mücke C; Minty A; Thiel E; Berdel WE
Cancer Res; 1996 Aug; 56(15):3583-8. PubMed ID: 8758930
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
Shimabukuro T; Ohmoto Y; Naito K
J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
[TBL] [Abstract][Full Text] [Related]
16. Studies on the interaction between interleukin 6 and human malignant nonhematopoietic cell lines.
Serve H; Steinhauser G; Oberberg D; Flegel WA; Northoff H; Berdel WE
Cancer Res; 1991 Aug; 51(15):3862-6. PubMed ID: 1855204
[TBL] [Abstract][Full Text] [Related]
17. Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response.
Leland P; Obiri N; Aggarwal BB; Puri RK
Oncol Res; 1995; 7(5):227-35. PubMed ID: 8534928
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.
Kioi M; Kawakami K; Puri RK
Cell Immunol; 2004 May; 229(1):41-51. PubMed ID: 15331327
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the interaction between interleukin-6 and human renal cell carcinoma cell line GRC-1].
Xi Z; Yu L; Guo Y
Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):308-11. PubMed ID: 11798778
[TBL] [Abstract][Full Text] [Related]
20. Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Frankenberger B; Pohla H; Noessner E; Willimsky G; Papier B; Pezzutto A; Kopp J; Oberneder R; Blankenstein T; Schendel DJ
Clin Cancer Res; 2005 Mar; 11(5):1733-42. PubMed ID: 15755994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
